Table 1 Characteristics of participants by the G−1606 A genotypes
Characteristic | Non-slavic | Slavic | ||
|---|---|---|---|---|
G−1606A | AA+GA (n=158) | GG (n=541) | AA+GA (n=115) | GG (n=378) |
Anthropometry | ||||
Women, n (%) | 86 (54.4) | 282 (52.1) | 53 (46.0) | 229 (60.6)* |
Age (years) | 47.9±15.6 | 47.5±14.6 | 35.2±13.5 | 37.1±14.3 |
Body height (cm) | 168.4±9.1 | 168.2±9.5 | 170.4±8.6 | 168.1±9.2 |
Body weight (kg) | 73.3±12.7 | 72.8±13.5 | 72.7±15.2 | 71.8±14.2 |
Waist-to-hip ratio | 0.85±0.08 | 0.86±0.08 | 0.84±0.08 | 0.82±0.09 |
Body mass index (kg m−2) | 25.8±3.8 | 25.7±4.0 | 25.0±4.8 | 25.5±5.1 |
Pulse rate (beats min−1) | 66.4±9.5 | 65.8±10.3 | 70.1±9.2 | 70.9±9.8 |
Systolic pressure (mm Hg) | 126.3±15.5 | 126.5±17.1 | 122.9±16.3 | 125.6±21.0 |
Diastolic pressure (mm Hg) | 78.7±9.2 | 79.5±10.0 | 80.1±10.5 | 80.8±12.9 |
Questionnaire data | ||||
Current smokers, n (%) | 30 (19.0) | 130 (24.0) | 33 (28.7) | 90 (23.8) |
Using ⩾5 g alcohol per day, n (%) | 66 (41.8) | 237 (43.8) | 42 (36.5) | 103 (27.3) |
On antihypertension treatment, n (%) | 36 (22.8) | 100 (18.5) | 15 (13.0) | 69 (18.3) |
Family history of hypertension, n (%) | 71 (44.9) | 219 (40.5) | 61 (53.0) | 172 (45.5) |
24-h urinary measurements | ||||
Volume (l day−1) | 1.76±0.70 | 1.67±0.72 | 1.47±0.50 | 1.37±0.50 |
Creatinine (mmol day−1) | 10.9±3.9 | 11.4±4.1 | 12.2±3.9 | 11.4±3.9 |
Sodium (mmol day−1) | 182.4±73.6 | 173.3±69.3 | 260.6±113.6 | 220.7±88.7† |
Potassium (mmol day−1) | 71.0±28.8 | 68.9±26.0 | 67.2±24.9 | 60.5±23.1* |
